| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/25/2007 | WO2006121467A3 Tetrahydrocarbazole derivatives for treating flaviridae viruses |
| 01/25/2007 | WO2006109317A8 A process for the preparation of poly dl-lactide-co-glycolide nanoparticles having antitubercular drugs encapsulated therein |
| 01/25/2007 | WO2006105219A3 T cell therapy for the treatment of cachexia and chronic diseases |
| 01/25/2007 | WO2006096285A3 Compositions and methods for treating or preventing flaviviridae infections |
| 01/25/2007 | WO2006076014A3 Interferon-alpha constructs for use in the treatment of sars |
| 01/25/2007 | WO2006032475A3 Staphylococcal immunogenic compositions |
| 01/25/2007 | WO2005118777A8 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 01/25/2007 | WO2005025556A3 Antibiotic cycloalkyltetrahydroquinoline derivatives |
| 01/25/2007 | US20070021596 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata, tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021476 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer' |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021449 Pyrimidine derivatives for the prevention of hiv infection |
| 01/25/2007 | US20070021438 Itraconazole solution |
| 01/25/2007 | US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 01/25/2007 | US20070021418 Method of inhibiting production of osteopontin |
| 01/25/2007 | US20070021416 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides |
| 01/25/2007 | US20070021410 Such as N-[1-(2-amino-3-methylbutyl)-4-piperidinyl]-3-[(2-methoxyethoxy)(6-methyl-2-pyridinyl)methyl]-7-methyl-3H-imidazo[4,5-b]pyridin-2-amine; infant infections |
| 01/25/2007 | US20070021390 thiazole, oxazole derivatives useful for treating neurodegenerative disorders or pain |
| 01/25/2007 | US20070021388 trans-stereochemistry to improve half life, oral bioavailability and activity; liver disorderslike liver cancer, liver infections, fibrosis, obesity; trans-4-(3-chlorophenyl)-2-(4-nitrophenoxy)-2-oxo-1,3,2-dioxaphosphorinane |
| 01/25/2007 | US20070021354 Viricides; immunomoderator; mixture with other Aids drugs |
| 01/25/2007 | US20070021330 cyclic peptides used as enzyme inhibitors, optionally mixed with carriers or excipients, and viricides selected from interferons, ribavirin and amantadine, for treatment of viral diseases |
| 01/25/2007 | US20070020384 Environmentally benign crop protection agents |
| 01/25/2007 | US20070020351 Antitubercular extracts of Salicornia brachiata |
| 01/25/2007 | US20070020348 Composition for treating hepatitis c |
| 01/25/2007 | US20070020322 Method for inhibiting the growth of antibiotic resistant of bacteria by using pentane-1, 5-diol |
| 01/25/2007 | US20070020309 Safe and effective biofilm inhibitory compounds and health related uses thereof |
| 01/25/2007 | US20070020296 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 01/25/2007 | US20070020290 Natural antibodieactive against HIV virus |
| 01/25/2007 | US20070020287 Virulence genes of M.marinum and M. tuberculosis |
| 01/25/2007 | US20070020280 Compositions and methods for inhibition of HIV-1 infection |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020260 Glycoprotein compositions |
| 01/25/2007 | US20070020257 Which induce an antibody specific to cell surface protein antigen from Streptococcus; use in vaccine production and preventing dental caries |
| 01/25/2007 | US20070017513 Method and apparatus for dispensing inhalator medicament |
| 01/25/2007 | DE102005033103A1 Heterocyclylamid-substituierte Thiazole, Pyrrole und Thiophene Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
| 01/25/2007 | CA2838108A1 Sustained release of antiinfectives |
| 01/25/2007 | CA2616122A1 Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
| 01/25/2007 | CA2616054A1 Novel bacterium belonging to the genus bifidobacterium and utilization of the same |
| 01/25/2007 | CA2615738A1 Bifunctional protein anchors |
| 01/25/2007 | CA2615716A1 Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers |
| 01/25/2007 | CA2614963A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 01/25/2007 | CA2614674A1 Antiviral compounds |
| 01/25/2007 | CA2578613A1 Binding domain fusion proteins |
| 01/24/2007 | EP1746159A2 Immunostimulatory nucleic acid molecules |
| 01/24/2007 | EP1746157A1 Method of proliferating plasma cell |
| 01/24/2007 | EP1746103A1 Bifunctional protein anchors |
| 01/24/2007 | EP1746098A1 Valacyclovir polymorphs and a process for the preparation thereof |
| 01/24/2007 | EP1746087A1 Derivates of 3-indolylmethylene having cytostatic properties |
| 01/24/2007 | EP1746086A1 Cyanopyrrolidine derivatives |
| 01/24/2007 | EP1745800A1 Novel blt2-mediated disease, and blt2 binding agent and compound |
| 01/24/2007 | EP1745798A2 Hcv vaccine compositions |
| 01/24/2007 | EP1745784A1 Oxazolidinone derivatives and use thereof as antibiotics |
| 01/24/2007 | EP1745780A1 Medicinal preparation |
| 01/24/2007 | EP1745778A2 Diaminoalcohols as therapeutic compounds |
| 01/24/2007 | EP1745777A1 Amido-aminoalcohols as therapeutic compounds |
| 01/24/2007 | EP1745573A2 METHODS OF MANUFACTURE OF 2 -DEOXY-&bgr;-L-NUCLEOSIDES |
| 01/24/2007 | EP1745053A1 Trihemihydrate, anhydrate and hydrate forms of cefdinir |
| 01/24/2007 | EP1745052A1 Hiv integrase inhibitors: cyclic pyrimidinone compounds |
| 01/24/2007 | EP1744781A1 Treatment of infectious diseases |
| 01/24/2007 | EP1744756A1 Use of meloxicam formulations in veterinary medicine |
| 01/24/2007 | EP1744729A2 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 01/24/2007 | EP1638547B1 Composition for preventing urinary system infections |
| 01/24/2007 | EP1575612B1 Immunogenic composition |
| 01/24/2007 | EP1423100B1 Plaster comprising sertaconazole for the treatment of dysfunctions and disorders of nails |
| 01/24/2007 | EP1383795B1 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 01/24/2007 | EP1341537B1 Pharmaceutically active isoindoline derivatives |
| 01/24/2007 | EP1339386B1 Reversible gelling system for ocular drug delivery |
| 01/24/2007 | EP1295126B1 Hepatitis c viral antigen immunoassay detection systems |
| 01/24/2007 | EP1181363B1 Recombinant human mannan-binding lectin |
| 01/24/2007 | EP1180028B1 Il-8 receptor antagonists |
| 01/24/2007 | EP0760000B1 Alphavirus expression vector |
| 01/24/2007 | EP0749321B1 Active immunization using a siderophore receptor protein |
| 01/24/2007 | CN1902223A Antiviral compositions which inhibit paramyxovirus infection |
| 01/24/2007 | CN1902216A Depeptidized inhibitors of hepatitis c virus NS3 protease |
| 01/24/2007 | CN1902207A Processes for the preparation of highly pure 3-(2-substituted vinyl) cephalosporin |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/24/2007 | CN1901924A Method for inhibiting bacterial colonisation |
| 01/24/2007 | CN1901923A Disinfecting composition and methods of making and using same |
| 01/24/2007 | CN1901921A Baicalin and its derivatives as a treatment for SARS coronavirus infection or other related infections |
| 01/24/2007 | CN1901892A Treating infectious diseases using ice inhibitors |
| 01/24/2007 | CN1900320A Diagnostic assay |
| 01/24/2007 | CN1900259A Health wine for preventing bird flu and its making method |
| 01/24/2007 | CN1900111A Recombinant tubercle bacillus antigen poly epitope peptide and its constructing method and use |
| 01/24/2007 | CN1900104A 3'-prodrugs of 2'-deoxy-beta-l-nucleosides |
| 01/24/2007 | CN1900091A Nucleotide analog compositions |
| 01/24/2007 | CN1900090A Nucleotide analog compositions |
| 01/24/2007 | CN1900089A Nucleotide analog compositions |
| 01/24/2007 | CN1900078A Entecavir potassium salt compound and its preparing method and medicine use |
| 01/24/2007 | CN1900077A New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
| 01/24/2007 | CN1899617A Compound econazole nitrate film forming gel composition and its use |
| 01/24/2007 | CN1899613A Therapeutic polypeptide hepatitis B vaccine and its preparing method and using method |
| 01/24/2007 | CN1899612A Therapeutical peptide hepatitis C vaccine and its preparing method |
| 01/24/2007 | CN1899611A Therapeutical polypeptide hepatitis B vaccine and its preparing method |
| 01/24/2007 | CN1899610A Pyloric spiral bacillus antigen recombinant vaccine |
| 01/24/2007 | CN1899608A Vaccine for preventing and treating aspergillin infection and its preparing method |
| 01/24/2007 | CN1899604A Rectal suppository of protein medicines and its preparing method and use in systemic disease therapy |
| 01/24/2007 | CN1899603A Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals |
| 01/24/2007 | CN1899600A Antibiotic peptide spray film forming agent and its preparing method |
| 01/24/2007 | CN1899599A Method for preparing Nosiheptide premixed agent |